Published in Blood on March 10, 2009
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res (2013) 2.57
Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proc Natl Acad Sci U S A (2010) 2.07
MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20). Proc Natl Acad Sci U S A (2012) 1.89
EpCAM knockdown alters microRNA expression in retinoblastoma--functional implication of EpCAM regulated miRNA in tumor progression. PLoS One (2014) 1.39
Role of microRNAs in lymphoid biology and disease. Curr Opin Hematol (2011) 1.22
Complete characterization of the microRNAome in a patient with acute myeloid leukemia. Blood (2010) 1.16
Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma. Haematologica (2010) 1.00
A capture-sequencing strategy identifies IRF8, EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma. Blood (2013) 1.00
MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response. Haematologica (2011) 0.97
Regulation of B-cell development and function by microRNAs. Immunol Rev (2013) 0.95
MicroRNA signatures in B-cell lymphomas. Blood Cancer J (2012) 0.95
Long non-coding RNAs in colorectal cancer. Oncotarget (2016) 0.92
Micro-RNA Expression and Function in Lymphomas. Adv Hematol (2011) 0.90
Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling. Blood (2012) 0.88
Development and blind clinical validation of a microRNA based predictor of response to treatment with R-CHO(E)P in DLBCL. PLoS One (2015) 0.88
MicroRNA-124 links p53 to the NF-κB pathway in B-cell lymphomas. Leukemia (2015) 0.87
Overexpression of microRNAs from the miR-17-92 paralog clusters in AIDS-related non-Hodgkin's lymphomas. PLoS One (2011) 0.87
A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignancies. Leukemia (2014) 0.87
Serum microRNAs in HIV-infected individuals as pre-diagnosis biomarkers for AIDS-NHL. J Acquir Immune Defic Syndr (2014) 0.85
D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2. Nat Commun (2015) 0.83
MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterparts. Blood Cancer J (2011) 0.81
A phosphodiesterase 4B-dependent interplay between tumor cells and the microenvironment regulates angiogenesis in B-cell lymphoma. Leukemia (2015) 0.80
MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies. ISRN Hematol (2013) 0.80
Role of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL). Leuk Res (2013) 0.80
Single-nucleotide polymorphisms among microRNA: big effects on cancer. Chin J Cancer (2011) 0.79
Clonal heterogeneity of lymphoid malignancies correlates with poor prognosis. Cancer Sci (2014) 0.79
Promising personalized therapeutic options for diffuse large B-cell Lymphoma Subtypes with oncogene addictions. Clin Cancer Res (2012) 0.79
MicroRNAs in diffuse large B-cell lymphoma. Oncol Lett (2015) 0.76
Micro-classifying diffuse large B-cell lymphomas. Blood (2009) 0.76
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer (2006) 46.47
A microRNA polycistron as a potential human oncogene. Nature (2005) 40.21
Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2002) 32.26
c-Myc-regulated microRNAs modulate E2F1 expression. Nature (2005) 31.81
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res (2005) 29.17
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A (2004) 28.29
Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet (2007) 15.46
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med (2002) 14.01
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood (2003) 13.92
Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science (2007) 12.42
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood (2004) 11.07
Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet (2007) 10.78
Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol (2008) 10.42
Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol (2008) 10.28
Serum microRNAs are promising novel biomarkers. PLoS One (2008) 8.69
microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A (2006) 8.24
Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res (2004) 7.96
Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J (2007) 6.26
HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell (2007) 6.06
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci U S A (2008) 5.90
MicroRNA profiling of the murine hematopoietic system. Genome Biol (2005) 4.94
Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. Clin Cancer Res (2005) 4.84
An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol (2003) 4.49
SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma. Blood (2007) 3.52
Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol Cell Biol (2007) 3.51
The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res (2008) 3.21
microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood (2009) 2.58
Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood (2008) 2.36
The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Proc Natl Acad Sci U S A (2007) 2.34
The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma. Proc Natl Acad Sci U S A (2007) 2.31
Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach. Blood (2005) 2.13
Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. Cancer Genet Cytogenet (2008) 2.01
The ins and outs of MYC regulation by posttranslational mechanisms. J Biol Chem (2006) 1.96
Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma. Blood (2005) 1.78
MicroRNA-513 regulates B7-H1 translation and is involved in IFN-gamma-induced B7-H1 expression in cholangiocytes. J Immunol (2009) 1.76
MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. Br J Haematol (2008) 1.60
The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. PLoS One (2008) 1.56
Mechanisms of MYC stabilization in human malignancies. Cell Cycle (2007) 1.43
Akt as a therapeutic target in cancer. Expert Opin Ther Targets (2008) 1.41
Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas. Blood (2005) 1.37
Molecular cytogenetic characterization of non-Hodgkin lymphoma cell lines. Genes Chromosomes Cancer (2002) 1.08
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med (2002) 14.01
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood (2004) 11.07
Germline mutations in TMEM127 confer susceptibility to pheochromocytoma. Nat Genet (2010) 2.23
Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proc Natl Acad Sci U S A (2010) 2.07
Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. Cancer Genet Cytogenet (2008) 2.01
MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20). Proc Natl Acad Sci U S A (2012) 1.89
College of American Pathologists' laboratory standards for next-generation sequencing clinical tests. Arch Pathol Lab Med (2014) 1.84
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea. Am J Gastroenterol (2005) 1.71
Protein tyrosine phosphatase receptor-type O truncated (PTPROt) regulates SYK phosphorylation, proximal B-cell-receptor signaling, and cellular proliferation. Blood (2006) 1.70
In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas. Endocr Relat Cancer (2013) 1.63
MicroRNA-155 controls RB phosphorylation in normal and malignant B lymphocytes via the noncanonical TGF-β1/SMAD5 signaling module. Blood (2013) 1.52
Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture. Antimicrob Agents Chemother (2008) 1.47
The phosphodiesterase PDE4B limits cAMP-associated PI3K/AKT-dependent apoptosis in diffuse large B-cell lymphoma. Blood (2004) 1.43
Large-scale synthesis of high-quality hexagonal boron nitride nanosheets for large-area graphene electronics. Nano Lett (2012) 1.41
Nanopatterned textile-based wearable triboelectric nanogenerator. ACS Nano (2015) 1.34
A prospective randomised study of a rotary powered device (OnControl) for bone marrow aspiration and biopsy. J Clin Pathol (2011) 1.32
Chronic gastrointestinal symptoms and quality of life in the Korean population. World J Gastroenterol (2008) 1.31
BAL1 and BBAP are regulated by a gamma interferon-responsive bidirectional promoter and are overexpressed in diffuse large B-cell lymphomas with a prominent inflammatory infiltrate. Mol Cell Biol (2006) 1.29
The BAL-binding protein BBAP and related Deltex family members exhibit ubiquitin-protein isopeptide ligase activity. J Biol Chem (2003) 1.28
Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event. Mod Pathol (2009) 1.26
Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas. Hum Pathol (2005) 1.26
Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: involvement of PDGFRB and response to imatinib. Blood (2003) 1.14
Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia. J Mol Diagn (2008) 1.13
Array CGH analysis of chronic lymphocytic leukemia reveals frequent cryptic monoallelic and biallelic deletions of chromosome 22q11 that include the PRAME gene. Leuk Res (2008) 1.11
Application of immunohistochemistry in the diagnosis of non-Hodgkin and Hodgkin lymphoma. Arch Pathol Lab Med (2008) 1.10
Coaxial fiber supercapacitor using all-carbon material electrodes. ACS Nano (2013) 1.09
Hypoglycemic effect of crude exopolysaccharides produced by a medicinal mushroom Phellinus baumii in streptozotocin-induced diabetic rats. Life Sci (2005) 1.07
Transparent flexible graphene triboelectric nanogenerators. Adv Mater (2014) 1.06
The Effect of Nano-Silver Liquid against the White Rot of the Green Onion Caused by Sclerotium cepivorum. Mycobiology (2010) 1.03
Mimics of cutaneous lymphoma: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. Am J Clin Pathol (2013) 1.03
Fully rollable transparent nanogenerators based on graphene electrodes. Adv Mater (2010) 1.02
Rational combined targeting of phosphodiesterase 4B and SYK in DLBCL. Blood (2009) 1.02
Defective DNA-mismatch repair: a potential mediator of leukemogenic susceptibility in therapy-related myelodysplasia and leukemia. Genes Chromosomes Cancer (2002) 1.01
The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA. Mol Cancer Ther (2007) 1.01
Tuberculous otitis media: a clinical and radiologic analysis of 52 patients. Laryngoscope (2006) 1.00
Sound-driven piezoelectric nanowire-based nanogenerators. Adv Mater (2010) 1.00
A capture-sequencing strategy identifies IRF8, EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma. Blood (2013) 1.00
A stamped PEDOT:PSS-silicon nanowire hybrid solar cell. Nanotechnology (2012) 0.97
Control of electronic structure of graphene by various dopants and their effects on a nanogenerator. J Am Chem Soc (2010) 0.97
Crystal structure of the de-ubiquitinating enzyme UCH37 (human UCH-L5) catalytic domain. Biochem Biophys Res Commun (2009) 0.96
Non-mycosis fungoides cutaneous T-cell lymphomas: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. Am J Clin Pathol (2013) 0.96
A platform for large-scale graphene electronics--CVD growth of single-layer graphene on CVD-grown hexagonal boron nitride. Adv Mater (2013) 0.95
Immunomodulator agent-related lymphoproliferative disorders. Mod Pathol (2009) 0.94
Gene set enrichment analysis unveils the mechanism for the phosphodiesterase 4B control of glucocorticoid response in B-cell lymphoma. Clin Cancer Res (2011) 0.94
Efficacy of endoscopic mucosal resection using a dual-channel endoscope compared with endoscopic submucosal dissection in the treatment of rectal neuroendocrine tumors. Surg Endosc (2013) 0.93
A painful glomus tumor on the pulp of the distal phalanx. J Korean Neurosurg Soc (2010) 0.92
Highly stretchable piezoelectric-pyroelectric hybrid nanogenerator. Adv Mater (2013) 0.92
MicroRNA-155 expression and outcome in diffuse large B-cell lymphoma. Br J Haematol (2008) 0.91
Inhibitory effects of tricyclic antidepressants (TCAs) on human cytochrome P450 enzymes in vitro: mechanism of drug interaction between TCAs and phenytoin. Drug Metab Dispos (2002) 0.91
Piezoelectric touch-sensitive flexible hybrid energy harvesting nanoarchitectures. Nanotechnology (2010) 0.90
Mycosis fungoides: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. Am J Clin Pathol (2013) 0.90
The rGel/BLyS fusion toxin inhibits diffuse large B-cell lymphoma growth in vitro and in vivo. Neoplasia (2010) 0.90
A review of current disinfectants for gastrointestinal endoscopic reprocessing. Clin Endosc (2013) 0.90
Two-dimensional vanadium-doped ZnO nanosheet-based flexible direct current nanogenerator. ACS Nano (2013) 0.89
Controlled growth of semiconducting nanowire, nanowall, and hybrid nanostructures on graphene for piezoelectric nanogenerators. ACS Nano (2011) 0.89
Hydrophobic sponge structure-based triboelectric nanogenerator. Adv Mater (2014) 0.88
BRCA2 suppresses cell proliferation via stabilizing MAGE-D1. Cancer Res (2005) 0.87
Gender-specific metabolomic profiling of obesity in leptin-deficient ob/ob mice by 1H NMR spectroscopy. PLoS One (2013) 0.87
Free-standing ZnO nanorods and nanowalls by aqueous solution method. J Nanosci Nanotechnol (2008) 0.87
Nature of stress: differential effects on brain acetylcholinesterase activity and memory in rats. Life Sci (2005) 0.87
Breeding of new strains of mushroom by basidiospore chemical mutagenesis. Mycobiology (2011) 0.86
Synthesis and characterization of monodispersed β-Ga₂O₃ nanospheres via morphology controlled Ga₄(OH)₁₀SO₄ precursors. Langmuir (2015) 0.86
Mice heterozygous for CREB binding protein are hypersensitive to γ-radiation and invariably develop myelodysplastic/myeloproliferative neoplasm. Exp Hematol (2011) 0.86
p-Type polymer-hybridized high-performance piezoelectric nanogenerators. Nano Lett (2012) 0.86
Antimigration property of a newly designed covered metal stent for esophageal stricture: an in vivo animal study. Gastrointest Endosc (2011) 0.85
Peritumoral brain edema in meningiomas : correlation of radiologic and pathologic features. J Korean Neurosurg Soc (2011) 0.85
Paper-based piezoelectric nanogenerators with high thermal stability. Small (2011) 0.85
Striped, ellipsoidal particles by controlled assembly of diblock copolymers. J Am Chem Soc (2013) 0.84
Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification. Leuk Lymphoma (2003) 0.84
Inhibition Effects of Silver Nanoparticles against Powdery Mildews on Cucumber and Pumpkin. Mycobiology (2011) 0.84
Integrity of the CBL gene in mature B-cell malignancies. Blood (2009) 0.84
Effect of probiotic Lactobacillus (Lacidofil® cap) for the prevention of antibiotic-associated diarrhea: a prospective, randomized, double-blind, multicenter study. J Korean Med Sci (2010) 0.83
Home prothrombin time monitoring: a literature analysis. Am J Hematol (2004) 0.83
Diagnostic accuracy and interobserver agreement in predicting the submucosal invasion of colorectal tumors using gross findings, pit patterns, and microvasculatures. Clin Endosc (2013) 0.83
Cutaneous B-cell lymphoproliferative disorders: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. Am J Clin Pathol (2013) 0.83
Characteristic peripheral blood findings in human ehrlichiosis. Mod Pathol (2004) 0.82
Low-dose intravenous pantoprazole for optimal inhibition of gastric acid in Korean patients. J Gastroenterol Hepatol (2007) 0.82
Analysis of Clip-induced Ischemic Complication of Anterior Choroidal Artery Aneurysms. J Korean Neurosurg Soc (2008) 0.82
Clinical application of array-based comparative genomic hybridization for the identification of prognostically important genetic alterations in chronic lymphocytic leukemia. Mol Diagn Ther (2008) 0.81
Comparative genomic hybridization arrays in clinical pathology: progress and challenges. Mol Diagn Ther (2007) 0.81
Large B-cell lymphoma of the leg: clinical and pathologic characteristics in a North American series. J Am Acad Dermatol (2003) 0.81
Growth of high quality ZnO nanowires on graphene. J Nanosci Nanotechnol (2012) 0.81
CD56-positive large B-cell lymphoma. Appl Immunohistochem Mol Morphol (2006) 0.80
Cardiac troponin I elevation in patients with aneurysmal subarachnoid hemorrhage. J Korean Neurosurg Soc (2009) 0.80
Application of statistically based experimental designs for the optimization of exo-polysaccharide production by Cordyceps militaris NG3. Biotechnol Appl Biochem (2002) 0.80
Genetic introduction of foreign genes to Pleurotus eryngii by restriction enzyme-mediated integration. J Microbiol (2010) 0.80
Fluoride in groundwater: toxicological exposure and remedies. J Toxicol Environ Health B Crit Rev (2013) 0.79
Long term results of microsurgical dorsal root entry zonotomy for upper extremity spasticity. J Korean Neurosurg Soc (2008) 0.79
Differential expression of kidney proteins in streptozotocin-induced diabetic rats in response to hypoglycemic fungal polysaccharides. J Microbiol Biotechnol (2007) 0.79